학술논문

Fluoroquinolone resistance among clonal complex 1 group B Streptococcus strains
Document Type
Report
Source
Canadian Journal of Infectious Diseases and Medical Microbiology. Annual, 2016
Subject
Gene mutations -- Research -- Genetic aspects -- Usage
Nucleotide sequencing -- Usage -- Research -- Genetic aspects
Quinolone antibacterial agents -- Dosage and administration -- Research -- Usage
Drug resistance in microorganisms -- Research -- Genetic aspects
Quinolones -- Dosage and administration -- Research -- Usage
DNA sequencing -- Usage -- Research -- Genetic aspects
Streptococcus agalactiae -- Genetic aspects -- Research -- Usage
Language
English
ISSN
1712-9532
Abstract
Fluoroquinolone resistance in group B Streptococcus is increasingly being reported worldwide. Here, we correlated fluoroquinolone resistance with mutations in gyrA, gyrB, parC, and parE genes, identified by mining whole-genome sequencing (WGS) data of 190 clonal complex 1 group B Streptococcus strains recovered from patients with invasive diseases in North America. We report a high prevalence of fluoroquinolone resistance (12%) among GBS strains in our collection. Our approach is the first step towards accurate prediction of fluoroquinolone resistance from WGS data in this opportunistic pathogen.
1. Introduction Group B Streptococcus (GBS) causes neonatal sepsis and meningitis and is increasingly recognized as the causative agent of opportunistic infections in adults, particularly the elderly and those immunocompromised [...]